Over 10 years we helping companies reach their financial and branding goals. Onum is a values-driven SEO agency dedicated.


What secrets of health does Doctomatic’s AI hold?

Remote patient monitoring

Remote patient monitoring (RPM) represents a transformative approach in healthcare, leveraging technology to oversee patient health beyond the confines of standard clinical environments. It enables the monitoring of vital signs, symptoms, and medication adherence through various electronic methods. The significance of RPM is underscored by its utility in managing chronic illnesses, which are increasingly common among an aging demographic; in the U.S., chronic diseases affect 60% of adults, as reported in 2020.

In the vanguard of this healthcare revolution is Doctomatic, a trailblazing entity established in Spain. Co-founders Carmen Pauline Rios Benton and Frederic Llordachs-Marques launched the company on June 1, 2021.

Pain point addressed

The key challenge addressed by Doctomatic is the complexity and operational difficulties associated with traditional remote patient monitoring solutions. Their software streamlines the process by offering a device and condition-agnostic platform, eliminating the need for painful integrations with medical devices that often make such services cumbersome and sometimes inoperable. This approach directly tackles the pain point of integrating a diverse range of medical devices and patient conditions into a single, seamless remote monitoring service.

Type of solution

Doctomatic offers an AI-enhanced SaaS platform that streamlines remote patient monitoring by supporting seamless data capture from diverse medical devices, irrespective of their make or the conditions they monitor. This platform optimizes healthcare workflows, facilitating the consolidation and efficient handling of patient data. It also employs predictive analytics to anticipate potential health deterioration, thus aiding in the proactive management of chronic diseases.

Source: https://www.doctomatic.com/en/#providers

Type of input data leveraged

Doctomatic’s platform leverages health data input from non-invasive medical devices. Patients use these devices to collect various health metrics, which are then transmitted via a mobile app to Doctomatic’s medical platform. Here, the data is analyzed and evaluated by medical professionals to monitor and make informed decisions about their patients’ health.

Key technology used

The key technology underpinning Doctomatic’s platform is artificial intelligence (AI), which encompasses machine learning (ML) algorithms. These ML algorithms are trained to analyze large datasets, recognize patterns, and make predictions based on health data collected from patients. The platform’s AI component is crucial for parsing through the continuous stream of health metrics, identifying trends or anomalies that may indicate a change in the patient

Key applications of solution

  • Doctomatic’s key application is in remote patient monitoring, where its platform serves as a critical tool for healthcare providers. By leveraging the data collected from various non-invasive medical devices, the platform enables continuous health tracking.
  • The software’s core functionality includes diagnostic assistance, where AI algorithms help in interpreting health data to identify signs of patient health deterioration.
  • It is also used for treatment planning, enabling healthcare providers to tailor medical interventions based on real-time data.
  • The platform plays a significant role in personalized care, as the AI’s predictive analytics help in customizing healthcare plans to individual patient needs based on their health data trends.

Implications to stakeholders

Patients: They receive a tailored healthcare experience where continuous health monitoring can lead to early detection of adverse conditions, enabling prompt and more targeted healthcare interventions.

Healthcare providers: Clinicians benefit from an enhanced decision-support system, which processes health data through advanced algorithms, reducing the manual burden of data analysis. This facilitates a more efficient allocation of time towards patient care rather than data management.

Insurers: The predictive analytics component of the platform may lead to a decrease in the frequency and severity of claims by preventing acute exacerbations of chronic conditions, thereby optimizing risk management and cost savings.

Regulatory bodies: The use of AI in processing sensitive health data brings Doctomatic under the scrutiny of data protection and patient privacy regulations, necessitating strict adherence to compliance standards such as GDPR in the EU.

Current impact

The impact of Doctomatic is evident in its integration with a wide array of medical devices from companies such as Fitbit for activity tracking, Omron for blood pressure monitoring, and Dexcom for glucose monitoring. This interoperability allows the platform to accommodate a multitude of health conditions and assist healthcare professionals in closely monitoring patient health metrics. Consequently, this facilitates timely medical decisions and interventions, crucial for managing chronic health issues.

Potential future impact

The potential impact of Doctomatic is significant. If its AI-driven predictive analytics can reliably forecast health deterioration, it could revolutionize chronic disease management by enabling preventative care models. This anticipatory approach could reduce emergency hospital visits and readmissions, thereby decreasing healthcare costs and improving patient outcomes.

In the future, Doctomatic could broaden its reach by integrating with more devices and expanding its AI capabilities, thus enhancing its predictive accuracy. This expansion can lead to a more personalized and precise healthcare provision tailored to individual patient profiles. As healthcare continues to evolve toward a more data-driven model, Doctomatic’s platform has the potential to become a critical tool in the shift toward proactive rather than reactive medical care.

Business model

Doctomatic operates on a B2B (Business-to-Business) model, primarily targeting healthcare providers and professionals who manage chronic patients remotely. The platform adopts a subscription-based revenue model, wherein healthcare entities pay a recurring fee to access the service.

Advantages of the business model

  • Recurring revenue stream: A subscription model ensures a steady and predictable income, which can be essential for sustaining long-term development and operational costs.
  • Scalability: As healthcare providers onboard more patients onto the Doctomatic platform, the subscription model can scale accordingly, providing a growth pathway that aligns with customer expansion.
  • Client retention: Subscription models often come with contracts that encourage longer-term commitments, which can lead to higher client retention rates.
  • Continuous improvement: The recurring revenue allows Doctomatic to invest in the continuous improvement of its AI algorithms and platform functionality, which in turn can lead to better service for clients.

Funding and key investors

Doctomatic has secured funding, with the most recent deal type being an Early Stage VC (Venture Capital), with an upcoming deal amounting to $200K. The company has two investors backing this funding round. The identities of these key investors or additional details about the funding specifics were not disclosed in the available data. Doctomatic has completed two seed funding rounds. The first seed round took place on September 1, 2021, raising $235K. The subsequent seed round occurred on April 26, 2022, where they secured an additional $420K, bringing the total capital raised across both rounds to $655K.

Competitive differentiator

Doctomatic distinguishes itself in the market with its AI-powered platform that is compatible with any medical device and adaptable to all health conditions, providing healthcare providers with a flexible and scalable patient monitoring solution. Its focus on AI for predictive analytics enhances proactive patient care, setting it ahead of traditional, reactive models and marking its edge over less versatile competitors.

Relevant regulatory and compliance requirements

For a company like Doctomatic, which handles sensitive patient data, compliance with health data protection regulations such as the General Data Protection Regulation (GDPR) in the EU and potentially others like the Health Insurance Portability and Accountability Act (HIPAA) in the US, if they operate there, could be essential.

It’s important for such companies to maintain rigorous standards for data security and privacy, ensuring that patient information is handled securely and in compliance with all applicable laws and regulations. This is not only a legal requirement but also critical for maintaining user trust and safeguarding against data breaches.

Partnerships and collaborations

For Doctomatic, forming partnerships with medical device manufacturers, healthcare institutions, and technology firms could be crucial for growth and innovation. Such collaborations could potentially extend the functionality and reach of their platform, integrate with other health management systems, and facilitate entry into new markets.

Areas for continuous improvement

  • Data privacy and security: As they handle sensitive health data, continuously improving cybersecurity measures and ensuring compliance with global data protection regulations could be crucial.
  • Integration capabilities: Further developing integration capabilities with a wider range of medical devices and health management systems could improve versatility.
  • Advanced analytics: Incorporating more advanced predictive analytics and machine learning algorithms could provide even more accurate health insights.




Disclaimer: Please note that the opinions, content, and analysis in my posts are entirely my own and do not reflect the views of any current or past employers or institutional affiliations. These posts, based solely on publicly available information, are for informational purposes and should not be taken as professional advice. All insights and conclusions are my viewpoints and should not be considered representative of any organizations I am or have been associated with. This content is not endorsed by, nor does it represent the stance of any affiliated entity.


Hiequity Team

Leave a comment

Your email address will not be published. Required fields are marked *